Voyager Therapeutics (VYGR) Revenue (2015 - 2026)
Voyager Therapeutics (VYGR) reported Revenue of $3.2 million for Q2 2026, down 38.5% from $5.2 million a year earlier but up 23.1% from the prior quarter.
Powered by 
Analysis
Voyager Therapeutics (VYGR) Revenue (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Voyager Therapeutics' Revenue came in at $34.54 million, down 18.9% year-over-year; for FY2025, it came in at $40.37 million, down 49.5% from FY2024.
- Revenue has a five-year compound annual growth rate of -25.1% (FY2020 to FY2025).
- By year, Revenue came in at $80 million in FY2024 (-68.0%), $250.01 million in FY2023 (+511.2%), $40.91 million in FY2022 (+9.3%) and $37.42 million in FY2021 (-78.1%).
- Five-year quarterly Revenue spans a low of -$1.55 million in Q4 2022 and a high of $150.48 million in Q1 2023.
- Year over year, Revenue gained in two of the last eight quarters, with growth averaging 24.0%.
- The high point for year-over-year Revenue in five years was Q2 2023 (growth of 588.2%); the low point was Q3 2021 (a decline of 98.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.6 million (Q1 2026), $15.34 million (Q4 2025) and $13.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Voyager Therapeutics | 163.60 Mn | -499.59 Mn | - | 3.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.20 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 15.34 Mn |
| Sep 30, 2025 | 13.40 Mn |
| Jun 30, 2025 | 5.20 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 6.28 Mn |
| Sep 30, 2024 | 24.63 Mn |
| Jun 30, 2024 | 29.60 Mn |
| Mar 31, 2024 | 19.52 Mn |
| Dec 31, 2023 | 90.06 Mn |
| Sep 30, 2023 | 4.61 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 150.48 Mn |
| Dec 31, 2022 | -1.55 Mn |
| Sep 30, 2022 | 41.09 Mn |
| Jun 30, 2022 | 712,000.00 |
| Mar 31, 2022 | 658,000.00 |
| Dec 31, 2021 | 28.07 Mn |
| Sep 30, 2021 | 1.48 Mn |
API Access
Voyager Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VYGR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();